Laviana Pharma Attends the 2023 BIO International Convention along its Cangzhou GMP Manufacturing Base Project
From June 5th to 8th, the high-profile well-anticipated 2023 BIO International Convention was convened by the Boston Convention & Exhibition Center in the United States. This grand distinguished event had attracted biopharmaceutical companies, investors, and partners worldwide. A variety of cooperative activities were held during the exhibition, providing a platform of presentation and promotion for global enterprises, technology parks, and R&D institutions. With the Cangzhou GMP manufacturing base project, Laviana Pharma made its appearance at this conference, presenting the Company's latest innovative R&D achievements in the Contract Development and Manufacturing Organization (CDMO) industry.